Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Converg Sci Phys Oncol. 2018 Jan 16;4(1):015003. doi: 10.1088/2057-1739/aaa00b

Table 1.

Summary of observed CNAs. Gene functions, alteration types, and implications are displayed with the frequencies of occurrence in MTCs, BMTP, and PTTP

Gene Function Type of alteration MTCs BMTP PTTP Implications
PTEN Tumor suppressor Deletion 77% (17/22) 0% (0/17) 34% (11/32) Increased cell proliferation and reduced cell death due to dysfunction in cell cycle regulation
RB1 Tumor suppressor Hemizygous Deletion 0% (0/22) 23% (4/17) 0% (0/32) Excessive cell growth due to dysregulation of cell cycle inhibition
TP53 Tumor suppressor Deletion 68% (15/22) 82% (14/17) 0% (0/32) Dysfunction in DNA repair activation, cell cycle inhibition, activation of apoptosis and senescence response to short telomeres
ATM Coordinates DNA repair Deletion 77% (17/22) 94% (16/17) 47% (15/32) Dysfunction in recognition of DNA damage and activation of DNA repair pathways
BRCA1 Tumor suppressor DNA repair Deletion 9% (2/22) 29% (5/17) 9% (3/32) Dysfunction in repairing damaged DNA properly. Cell can no longer sense DNA damage and sent appropriate signals
BRCA2 Tumor suppressor DNA repair Hemizygous deletion 0% (0/22) 23% (4/17) 0% (0/32) Dysfunction in repairing damaged DNA properly. BRCA2 directly binds DNA and interact with other protein to initiation strand invasion during repair
CDK2 Cell cycle regulator Deletion 36% (8/22) 23% (4/17) 9% (3/32) Dysfunction in cell cycle regulation specifically G1-S transition
MLH1 DNA mismatch repair Deletion 0% (0/22) 2% (3/17) 19% (6/32) Dysfunction in DNA specifically in recognition and initiation of mismatch repair, therefore, elevating spontaneous mutation rate
NCOA2 Transcription co-regulator Amplification 68% (15/22) 100% (17/17) 28% (9/32) Upregulation of DNA expression for nuclear hormone receptors such as AR and ESR1
MYC Transcription factor Amplification 0% (0/22) 12% (2/17) 3% (1/32) Upregulation of many genes involved in cell proliferation and cellular transformation via DNA over-replication
NKX3.1 Tumor suppressor Deletion 73% (16/22) 94% (16/17) 50% (16/32) As a transcription factor with critical function in prostate development NKX3.1 deletion results in increase prostate epithelial cell growth
AR Transcription factor Amplification 0% (0/22) 0% (0/17) 0% (0/32) As a transcription factor, AR amplification results in DNA over expression of genes such as IGFR and PSA that promote cell proliferation
ETV6 Transcription factor Deletion 45% (10/22) 41% (7/17) 6% (2/32) As a transcription factor it interacts with DNA to mostly inhibit transcription of its target genes that regulate both differentiation and cell growth
polyploidy Numerical change in a whole set of chromosomes 64% (14/22) 0% (0/17) 0% (0/32) Polyploidy occurs due to abnormal cell division and have associated with TP53 deletion